首站-论文投稿智能助手
典型文献
Structural overview and perspectives of the nuclear receptors,a major family as the direct targets for small-molecule drugs
文献摘要:
The nuclear receptors(NRs)are an evolutionarily related family of transcription factors,which share certain common structural characteristics and regulate the expressions of various genes by recognizing different response elements.NRs play important roles in cell differentiation,proliferation,survival and apoptosis,rendering them indispensable in many physiological activities including growth and metabolism.As a result,dysfunctions of NRs are closely related to a variety of diseases,such as diabetes,obesity,infertility,inflammation,the Alzheimer's disease,cardiovascular diseases,prostate and breast cancers.Meanwhile,small-molecule drugs directly targeting NRs have been widely used in the treatment of above diseases.Here we summarize recent progress in the structural biology studies of NR family proteins.Compared with the dozens of structures of isolated DNA-binding domains(DBDs)and the striking more than a thousand of structures of isolated ligand-binding domains(LBDs)accumulated in the Protein Data Bank(PDB)over thirty years,by now there are only a small number of multi-domain NR complex structures,which reveal the integration of different NR domains capable of the allosteric signal transduction,or the detailed interactions between NR and various coregulator proteins.On the other hand,the structural information about several orphan NRs is still totally unavailable,hindering the further understanding of their functions.The fast development of new technologies in structural biology will certainly help us gain more comprehensive information of NR structures,inspiring the discovery of novel NR-targeting drugs with a new binding site beyond the classic LBD pockets and/or a new mechanism of action.
文献关键词:
作者姓名:
Fengwei Li;Chun Song;Youming Zhang;Dalei Wu
作者机构:
Helmholtz International Lab,State Key Laboratory of Microbial Technology,Shandong University,Qingdao 266237,China
引用格式:
[1]Fengwei Li;Chun Song;Youming Zhang;Dalei Wu-.Structural overview and perspectives of the nuclear receptors,a major family as the direct targets for small-molecule drugs)[J].生物化学与生物物理学报(英文版),2022(01):12-24
A类:
coregulator
B类:
Structural,overview,perspectives,nuclear,receptors,major,family,targets,small,molecule,drugs,NRs,evolutionarily,related,transcription,factors,which,share,common,structural,characteristics,regulate,expressions,various,genes,by,recognizing,response,elements,play,important,roles,cell,differentiation,proliferation,survival,apoptosis,rendering,them,indispensable,many,physiological,activities,including,growth,metabolism,result,dysfunctions,closely,variety,diseases,such,diabetes,obesity,infertility,inflammation,Alzheimer,cardiovascular,prostate,breast,cancers,Meanwhile,directly,targeting,have,been,widely,used,treatment,above,Here,summarize,recent,progress,biology,studies,proteins,Compared,dozens,structures,isolated,binding,domains,DBDs,striking,more,than,thousand,ligand,LBDs,accumulated,Protein,Data,Bank,PDB,thirty,years,now,there,only,number,multi,complex,reveal,integration,capable,allosteric,signal,transduction,detailed,interactions,between,On,other,hand,information,about,several,orphan,still,totally,unavailable,hindering,further,understanding,their,fast,development,new,technologies,will,certainly,help,gain,comprehensive,inspiring,discovery,novel,site,beyond,classic,pockets,mechanism
AB值:
0.631759
相似文献
Drug repurposing for cancer treatment through global propagation with a greedy algorithm in a multilayer network
Xi Cheng;Wensi Zhao;Mengdi Zhu;Bo Wang;Xuege Wang;Xiaoyun Yang;Yuqi Huang;Minjia Tan;Jing Li-Department of Bioinformatics and Biostatistics,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;The Chemical Proteomics Center and State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Key Laboratory of Tissue Microenvironment and Tumor,Shanghai Institute of Nutrition and Health,Shanghai Institutes for Biological Sciences,University of Chinese Academy of Sciences,Chinese Academy of Sciences(CAS),Shanghai 200031,China
Structural insights into ligand recognition and selectivity of somatostatin receptors
Wenli Zhao;Shuo Han;Na Qiu;Wenbo Feng;Mengjie Lu;Wenru Zhang;Mu Wang;Qingtong Zhou;Shutian Chen;Wei Xu;Juan Du;Xiaojing Chu;Cuiying Yi;Antao Dai;Liaoyuan Hu;Michelle Y.Shen;Yaping Sun;Qing Zhang;Yingli Ma;Wenge Zhong;Dehua Yang;Ming-Wei Wang;Beili Wu;Qiang Zhao-State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,China;University of Chinese Academy of Sciences,Beijing,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,UCAS,Hangzhou,Zhejiang,China;Department of Pharmacology,School of Basic Medical Sciences,Fudan University,Shanghai,China;School of Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing,Jiangsu,China;School of Life Science and Technology,ShanghaiTech University,Shanghai,China;The National Center for Drug Screening,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,China;Amgen Asia R&D Center,Shanghai,China;Regor Therapeutics,Shanghai,China;Zhongshan Institute of Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan,Guangdong,China
Structures of the endogenous peptide-and selective non-peptide agonist-bound SSTR2 signaling complexes
Li-Nan Chen;Wei-Wei Wang;Ying-Jun Dong;Dan-Dan Shen;Jia Guo;Xuefei Yu;Jiao Qin;Su-Yu Ji;Huibing Zhang;Qingya Shen;Qiaojun He;Bo Yang;Yan Zhang;Qinglin Li;Chunyou Mao-Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital,Zhejiang University,School of Medicine,Hangzhou,Zhejiang,China;Department of General Surgery,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Center for Structural Pharmacology and Therapeutics Development,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,Zhejiang,China;The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Hangzhou,Zhejiang,China;Zhejiang Province Key Laboratory of Anti-Cancer Drug Research,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;MOE Frontier Science Center for Brain Research and Brain-Machine Integration,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Zhejiang Provincial Key Laboratory of Immunity and Inflammatory diseases,Hangzhou,Zhejiang,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。